Perspective Therapeutics (CATX) Debt to Equity (2023 - 2025)
Historic Debt to Equity for Perspective Therapeutics (CATX) over the last 3 years, with Q3 2025 value amounting to $0.01.
- Perspective Therapeutics' Debt to Equity rose 3105.73% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year increase of 3105.73%. This contributed to the annual value of $0.01 for FY2024, which is 7492.28% down from last year.
- Per Perspective Therapeutics' latest filing, its Debt to Equity stood at $0.01 for Q3 2025, which was up 3105.73% from $0.01 recorded in Q2 2025.
- In the past 5 years, Perspective Therapeutics' Debt to Equity ranged from a high of $0.02 in Q4 2023 and a low of $0.0 during Q2 2024
- Over the past 3 years, Perspective Therapeutics' median Debt to Equity value was $0.01 (recorded in 2025), while the average stood at $0.01.
- In the last 5 years, Perspective Therapeutics' Debt to Equity tumbled by 7492.28% in 2024 and then soared by 3105.73% in 2025.
- Perspective Therapeutics' Debt to Equity (Quarter) stood at $0.02 in 2023, then crashed by 74.92% to $0.01 in 2024, then increased by 16.9% to $0.01 in 2025.
- Its Debt to Equity was $0.01 in Q3 2025, compared to $0.01 in Q2 2025 and $0.01 in Q1 2025.